Market Currents
Shares of Halozyme Therapeutics (HALO) fall 23.1% premarket before tripping up circuit breakers....
-
Monday, April 16, 2012, 9:17 AM ETShares of Halozyme Therapeutics (HALO) fall 23.1% premarket before tripping up circuit breakers. All the fuss is over an announcement from the company that says the FDA requested more information on its HyQ Biologics Application before it can complete its review.
Other date
Latest Articles
